L-cysteine administration attenuates pancreatic fibrosis induced by TNBS in rats by inhibiting the activation of pancreatic stellate cell

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Yang, LiJuan ^a   Shen, JiaQing ^a   He, ShanShan ^b   Hu, GuoYong ^b   Shen, Jie ^b   Wang, Feng ^b   Xu, Ling ^b   Dai, WeiQi ^b   Xiong, Jie ^b   Ni, JianBo ^b   Guo, ChuanYong ^b   Wan, Rong ^b   Wang, XingPeng ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BROXURIDINE; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA1; CYSTEINE; GELATINASE A; GLUTATHIONE; HEME OXYGENASE 1; HYDROXYPROLINE; INTERLEUKIN 1BETA; MESSENGER RNA; OXIDOREDUCTASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; QUININE OXIDOREDUCTASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; TRINITROBENZENESULFONIC ACID;

AMINO ACID ANALYSIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL CYCLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DNA SYNTHESIS; DOWN REGULATION; DRUG MECHANISM; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HO 1 GENE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; NQO1 GENE; NRF2 GENE; OXIDATIVE STRESS; PANCREAS INJURY; PANCREATIC STELLATE CELL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; CHRONIC PANCREATITIS; DRUG EFFECT; FIBROSIS; PANCREAS DISEASE; PATHOLOGY; TREATMENT OUTCOME;

ANIMALS; CYSTEINE; FIBROSIS; PANCREATIC DISEASES; PANCREATIC STELLATE CELLS; PANCREATITIS, CHRONIC; RATS; TREATMENT OUTCOME; TRINITROBENZENESULFONIC ACID;

EID: 84863153557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031807     Document Type: Article

References (60)

1. Apte MV, Wilson JS, (2004) Mechanisms of pancreatic fibrosis. Dig Dis 22: 272-279.
2. Clain JE, Pearson RK, (1999) Diagnosis of chronic pancreatitis: is a gold standard necessary? Surg Clin North Am 79: 829-845.
3. Khalid A, Whitcomb DC, (2002) Conservative management of chronic pancreatitis. Eur J Gastroenterol Hepatol 14: 943-949.
4. Laugier R, Grandval P, (2002) Interventional treatment of chronic pancreatitis. Eur J Gastroenterol Hepatol 14: 951-955.
5. Levy MJ, Wiersema MJ, (2003) EUS-guided celiac plexus neurolysis and celiac plexus block. Gastrointest Endosc 57: 923-930.
6. Freiss H, Berberat PO, Wirtz M, Buchler MW, (2002) Surgical treatment and long-term follow up in chronic pancreatitis. Gastroenterol Hepatol 14: 971-977.
7. Zhang W, Gao J, Zhao T, Wu W, Bai Y, et al. (2010) High-dose naproxen aggravates pancreatic fibrosis in a rat model of chronic pancreatitis. Pancreas 39: 293-300.
8. Neuschwander-Tetri BA, Bridle KR, Wells LD, Marcu M, Ramm GA, (2000) Repetitive acute pancreatic injury in the mouse induces procollagen alpha1(I) expression colocalized to pancreatic stellate cells. Lab Invest 80: 143-150.
9. Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL, et al. (1999) Activation of pancreatic stellate cells in human and experimental pancreatic fibrosis. Am J Pathol 155: 1087-1095.
10. Casini A, Galli A, Pignalosa P, Frulloni L, Grappone C, et al. (2000) Collagen type I synthesized by periacinar stellate cells (PSC) co-localizes with lipid peroxidationderived aldehydes in chronic alcoholic pancreatitis. J Pathol 192: 81-89.
11. Ebert M, Kasper HU, Hernberg S, Friess H, Buchler MW, et al. (1998) Over expression of platelet derived growth factor (PDGF) B chain and type B PDGF receptor in human chronic pancreatitis. Dig Dis Sci 43: 567-574.
12. Talukdar R, Tandon RK, (2008) Pancreatic stellate cells: New target in the treatment of chronic pancreatitis. Journal of Gastroenterology and Hepatology 23: 34-41.
13. Schneider E, Schmid-Kotsas A, Zhao J, Weidenbach H, Schmid RM, et al. (2001) Identification of mediators stimulating proliferation and matrix synthesis of rat pancreatic stellate cells. Am J Physiol Cell Physiol 281: 532-543.
14. Kruse ML, Hildebrand PB, Timke C, Folsch UR, Schimdt WE, (2000) TGF-β1 autocrine growth control in isolated pancreatic fibroblast cells/stellate cells in vitro. Regul Pept 90: 47-52.
15. Martensson J, Bolin T, (1986) Sulfur amino acid metabolism in chronic relapsing pancreatitis. Am J Gastroenterol 81: 1179-1184.
16. Jesnowski R, Furst D, Ringel J, Chen Y, Schrodel A, et al. (2005) Immortalization of pancreatic stellate cells as an in vitro model of pancreatic fibrosis: deactivation is induced by matrigel and N-acetylcysteine. Lab Invest 85: 1276-1291.
17. Apte MV, Phillips PA, Fahmy RG, Darby SJ, Rodgers SC, et al. (2000) Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology 118: 780-794.
18. Horie T, Sakaida I, Yokoya F, Nakajo M, Sonakaa I, et al. (2003) L-cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activation. Biochemical and Biophysical Research Communications 305: 94-100.
19. Puig-Divi V, Molero X, Salas A, Guarner F, Guarner L, et al. (1996) Induction of chronic pancreatic disease by trinitrobenzene sulfonic acid infusion into rat pancreatic ducts. Pancreas 13: 417-424.
20. Puig-Divi V, Molero X, Vaquero E, Salas A, Guarner F, et al. (1999) Ethanol feeding aggravates morphological and biochemical parameters in experimental chronic pancreatitis. Digestion 60: 166-174.
21. Reddy GK, Enwemeka CS, (1996) A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29: 225-229.
22. Apte MV, Haber PS, Applegate TL, Norton ID, McCaughan GW, et al. (1998) Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 43: 128-133.
23. Gukovskaya AS, Gukovsky I, Zaninovic V, Song M, Sandoval D, et al. (1997) Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J Clin Invest 100: 1853-1862.
24. Mareninova OA, Sung KF, Hong P, Lugea A, Pando SJ, et al. (2006) Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. J Biol Chem 281: 3370-3381.
25. Hu G, Shen J, Cheng L, Guo C, Xu X, et al. (2010) Reg4 protects against acinar cell necrosis in experimental pancreatitis. Gut 60: 820-828.
26. Girish BN, Rajesh G, Vaidyanathan K, Balakrishnan V, (2011) Alterations in plasma amino acid levels in chronic pancreatitis. JOP 12: 11-18.
27. Matsui H, Ikeda K, Nakajima YJ, Horikawa S, Imanishi Y, et al. (2004) Sulfur-containing amino acids attenuate the development of liver fibrosis in rats through down-regulation of stellate cell activation. Journal of Hepatology 40: 917-925.
28. Buchholz M, Kestler HA, Holzmann K, Ellenrieder V, Schneiderhan W, et al. (2005) Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype. J Mol Med 83: 795-805.
29. Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, et al. (1999) Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 44: 534-541.
30. Luttenberger TA, Schmid-Kotsas A, Menke A, Siech M, Beger H, et al. (2000) Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Invest 80: 47-55.
31. Jaster R, Sparmann G, Emmirich J, Liebe S, (2002) Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut 51: 579-584.
32. Van Laethem JL, Robberecht P, Resibois A, Deviere J, (1996) Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology 110: 576-582.
33. Yoo BM, Yeo M, Oh TY, Choi Jh, Kim WW, et al. (2005) Amelioration of pancreatic fibrosis in mice with defective TGF-beta signaling. Pancreas 30: e71-e79.
34. Kaplowitz N, Aw TY, Ookhtens M, (1985) The regulation of hepatic glutathione. Annu Rev Pharmacol Toxicol 25: 715-744.
35. Tateishi N, Higashi T, Shinya S, Naruse A, Sakamoto Y, (1974) Studies on the regulation of glutathione level in rat liver. J Biochem 75: 93-103.
36. Reed DJ, Orrenius S, (1977) The role of methionine in glutathione biosynthesis by isolated hepatocytes. Biochem Biophys Res Commun 77: 1257-1264.
37. Lemke M, Gorl N, Berg A, Weber H, Hennighausen G, et al. (2006) Influence of selenium treatment on the acute toxicity of dibutylin dichloride in rats. Pancreatology 6: 486-496.
38. Ohashi S, ishio A, Nakamura H, Asada M, Tamaki K, et al. (2006) Overexpression of redox-active protein thioredoxin-1 prevents development of chronic pancreatitis in mice. Antioxid Redox Signal 8: 1835-1845.
39. Tasci I, Deveci S, Isik AT, Comert B, Akay C, et al. (2007) Allopurinol in rat chronic pancreatitis: effects on pancreatic stellate cell activation. Pancreas 35: 366-371.
40. Yan MX, Li YQ, Meng M, Ren HB, Kou Y, (2006) Long-term high-fat diet induces pancreatic injuries via pancreatic microcirculatory disturbances and oxidative stress in rats with hyperlipidemia. Biochem Biophys Res Commun 347: 192-199.
41. Zeki S, Miura S, Suzuki H, Watanabe N, Adachi M, et al. (2002) Xanthine oxidase Y derived oxygen radicals play significant roles in the development of chronic pancreatitis in wbn/kob rats. J Gastroenterol Hepatol 17: 606-616.
42. Kirk GR, White JS, McKie L, Stevenson M, Young L, et al. (2006) Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. J Gastrointest Surg 10: 499-503.
43. Bhardwaj P, Garg PK, Maulik SK, Saraya A, Tandon RK, et al. (2009) A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 136: 149-159.
44. Yoo BM, Oh TY, Kim YB, Yeo M, Lee JS, et al. (2005) Novel antioxidant ameliorates the fibrosis and inflammation of cerulein-induced chronic pancreatitis in a mouse model. Pancreatology 5: 165-176.
45. Shimizu K, (2008) Pancreatic stellate cells: molecular mechanism of pancreatic fibrosis. J Gastroenterol Hepatol 23: S119-S121.
46. Phillips PA, McCarroll JA, Park S, Wu MJ, Pirola R, et al. (2003) Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellularmatrix turnover. Gut 52: 275-282.
47. Mews P, Phillips P, Fahmy R, Korsten M, Pirola R, et al. (2002) Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis. Gut 50: 535-541.
48. Bentrem DJ, Joehl RJ, (2003) Pancreas: healing response in critical illness. Crit Care Med 31: S582-589.
49. Vogelmann R, Ruf D, Wagner M, Adler G, Menke A, (2001) Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-beta1 transgenic mouse model. Am J Physiol Gastrointest Liver Physiol 280: G164-G172.
50. Shek FW, Benyon RC, Walker FM, McCrudden PR, Pender SL, et al. (2002) Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis. Am J Pathol 160: 1787-1798.
51. Bottinger EP, Jakubczak JL, Roberts IS, Mumy M, Hemmati P, et al. (1997) Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas. EMBO J 16: 2621-2633.
52. Marrache F, Tu SP, Bhagat G, Pendyala S, Osterreicher CH, et al. (2008) Overexpression of interleukin-1beta in the murine pancreas results in chronic pancreatitis. Gastroenterology 135: 1277-1287.
53. Enomoto A, Itoh K, Nagayoshi E, Haruta J, Kimura T, et al. (2001) High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci 59: 169-177.
54. Morimitsu Y, Nakagawa Y, Hayashi K, Fujii H, Kumagai T, et al. (2002) A sulforaphane analogue that potently activates the Nrf2-dependent detoxification pathway. J Biol Chem 277: 3456-3463.
55. Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, et al. (2005) Nrf2, a multi-organ protector? FASEB J 19: 1061-1066.
56. Villeneuve NF, Lau A, Zhang DD, (2010) Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases. Antioxid Redox Signal 13: 1699-1712.
57. Hayes JD, McMahon M, Chowdhry S, Dinkova-Kostova AT, (2010) Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. Antioxid Redox Signal 13: 1713-1748.
58. Khor TO, Huang MT, Kwon KH, Chan JY, Reddy BS, et al. (2006) Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis. Cancer Res 66: 11580-11584.
59. Chowdhry S, Nazmy MH, Meakin PJ, Dinkova-Kostova AT, Walsh SV, et al. (2010) Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic Biol Med 48: 357-371.
60. Omary MB, Lugea A, Lowe AW, Pandol SJ, (2007) The pancreatic stellate cell: a star on the rise in pancreatic diseases. Journal of Clinical Investigation 117: 50-59.